Quality of Life among Patients with Retinal Vein Occlusion: A Case-Control Study
- PMID: 33684018
- DOI: 10.1080/08820538.2021.1896750
Quality of Life among Patients with Retinal Vein Occlusion: A Case-Control Study
Abstract
Purpose: The purpose of this study was to evaluate health-related quality of life in patients with retinal vein occlusion (RVO) and investigate the possible risk factors for poor quality of life in patients with RVO.Methods: Participants in the study were 67 patients with RVO, 42 male and 25 female, mean-aged 73.1 ± 10.9 years, and 70 sex- and age-matched controls. Demographic data, lifestyle factors and medical history were recorded. All patients underwent best-corrected visual acuity measurement, dilated fundoscopy and optical coherence tomography. All participants completed two questionnaires assessing quality of life (EQ-5D, NEI VFQ-25). Risk factors for health-related quality of life in RVO patients were investigated.Results: Patients with RVO exhibited significantly lower composite score for VFQ-25 compared to controls (74.1 ± 3.8 vs. 91.7 ± 3.9 for patients and controls, respectively, p < .001). In addition, RVO patients had significantly lower EQ-5D Index score compared to controls (0.88 ± 0.15 vs. 0.92 ± 0.12 for patients and controls, respectively, p = .043). Risk factors associated with quality of life in patients with RVO were found the alcohol consumption, the presence of thyroidopathy, coagulation disorders, visual acuity in the eye with RVO, central retinal thickness, the type of edema, the presence of ischemia and the condition of external limiting membrane. In multivariate analysis, only alcohol consumption and visual acuity in the eye with RVO were found to be independent risk factors, affecting quality of life in RVO patients.Conclusions: Patients with RVO presented lower quality of life in comparison with controls. Potential risk factors should be taken into account and their early detection may improve quality of life in such patients and lead to targeted health policies.
Keywords: EQ-5D; Retinal vein occlusion; VFQ-25; quality; risk factors.
Similar articles
-
QUALITATIVE AND QUANTITATIVE FOLLOW-UP USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF RETINAL VEIN OCCLUSION TREATED WITH ANTI-VEGF: Optical Coherence Tomography Angiography Follow-up of Retinal Vein Occlusion.Retina. 2017 Jun;37(6):1176-1184. doi: 10.1097/IAE.0000000000001334. Retina. 2017. PMID: 27685676
-
CORRELATION OF MICROVASCULAR STRUCTURES ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY WITH VISUAL ACUITY IN RETINAL VEIN OCCLUSION.Retina. 2017 Sep;37(9):1700-1709. doi: 10.1097/IAE.0000000000001403. Retina. 2017. PMID: 27828907
-
Ischemic retinal vein occlusion: characterizing the more severe spectrum of retinal vein occlusion.Surv Ophthalmol. 2018 Nov-Dec;63(6):816-850. doi: 10.1016/j.survophthal.2018.04.005. Epub 2018 Apr 27. Surv Ophthalmol. 2018. PMID: 29705175 Review.
-
Vision-related quality of life in patients with retinal vein occlusion.Int Ophthalmol. 2024 Feb 26;44(1):114. doi: 10.1007/s10792-024-02916-1. Int Ophthalmol. 2024. PMID: 38409518
-
Comparison between Ozurdex and intravitreal anti-vascular endothelial growth factor treatment for retinal vein occlusion-related macular edema: A systematic review and meta-analysis of randomized controlled trials.Indian J Ophthalmol. 2019 Nov;67(11):1800-1809. doi: 10.4103/ijo.IJO_382_19. Indian J Ophthalmol. 2019. PMID: 31638037 Free PMC article.
Cited by
-
Intravitreal Administration Effect of Adipose-Derived Mesenchymal Stromal Cells Combined with Anti-VEGF Nanocarriers, in a Pharmaceutically Induced Animal Model of Retinal Vein Occlusion.Stem Cells Int. 2022 Feb 23;2022:2760147. doi: 10.1155/2022/2760147. eCollection 2022. Stem Cells Int. 2022. PMID: 35251186 Free PMC article.
-
Predictors of problems reported on the EQ-5D-3L dimensions among people with impaired vision in northern Portugal.Health Qual Life Outcomes. 2022 Sep 6;20(1):132. doi: 10.1186/s12955-022-02043-4. Health Qual Life Outcomes. 2022. PMID: 36068600 Free PMC article.
-
[Aflibercept in a real-world setting: the AURIGA study : 24-month results of the German cohort of treatment-naïve patients with macular edema following retinal vein occlusion receiving intravitreal aflibercept].Ophthalmologie. 2024 Aug;121(8):650-657. doi: 10.1007/s00347-024-02051-3. Epub 2024 Jul 8. Ophthalmologie. 2024. PMID: 38976039 German.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources